YARROW BIOSCIENCE, INC. Increase (Decrease) in Deferred Revenue
YARROW BIOSCIENCE, INC. (YARW) reported Increase (Decrease) in Deferred Revenue of -$8.53 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-11-07
- YARROW BIOSCIENCE, INC. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$8.08M.
- YARROW BIOSCIENCE, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$449.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$449.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$1.80M, a 117.39% decline from fiscal 2016.
- YARROW BIOSCIENCE, INC. increase (decrease) in deferred revenue for fiscal 2016 was $10.33M, a 28586.11% increase from fiscal 2015.
- YARROW BIOSCIENCE, INC. increase (decrease) in deferred revenue for fiscal 2015 was $36.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$8.08M derived: sum of 2 quarters · filed 2018-11-07 | -$8.53M 10-Q · filed 2018-11-07 | -$8.98M derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | -$8.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$8.53M 10-Q · filed 2018-08-01 | -$8.98M derived: sum of 3 quarters · filed 2018-08-01 | -$9.43M derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-03-31 | -$449.00K 10-Q · filed 2018-05-09 | -$898.00K derived: sum of 2 quarters · filed 2018-05-09 | -$1.35M derived: sum of 3 quarters · filed 2018-11-07 | -$1.80M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-12-31 | -$449.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$898.00K derived: sum of 2 quarters · filed 2018-11-07 | -$1.35M derived: sum of 3 quarters · filed 2018-11-07 | -$1.80M 10-K · filed 2018-03-28 |
| 2017-09-30 | -$449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$898.00K derived: sum of 2 quarters · filed 2018-11-07 | -$1.35M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$898.00K 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | -$449.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $10.33M 10-K · filed 2018-03-28 | |||
| 2015-12-31 | $36.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |